İsmail Çimen
Impact in
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease
- Biochemistry top 10%
Papers in
-
- Inflammatory mediators and NSAID effects 5
-
- Atherosclerosis and Cardiovascular Diseases 5
- Co-authors
- Sreeparna Banerjee (6 shared papers)Ebru Erbay (5 shared papers)Umut İnci Onat (5 shared papers)Begüm Kocatürk (4 shared papers)Özlem Tufanlı (4 shared papers)Christian Weber (6 shared papers)Syed Muhammad Hamid (3 shared papers)Berna Savaş (2 shared papers)
- Journals
- Science Translational Medicine (2 papers)Journal of Cellular Biochemistry (1 paper)Molecular Metabolism (1 paper)Basic Research in Cardiology (1 paper)Bioscience Reports (1 paper)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
İsmail Çimen
15 papers receiving 638 citations
Peers
Comparison fields: 5 of 88
- Cell Biology 140
- Biochemistry 45
- Immunology 124
- Cancer Research 80
- Molecular Biology 275
Countries citing papers authored by İsmail Çimen
This map shows the geographic impact of İsmail Çimen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Çimen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Çimen more than expected).
Fields of papers citing papers by İsmail Çimen
This network shows the impact of papers produced by İsmail Çimen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Çimen. The network helps show where İsmail Çimen may publish in the future.
Co-authors
The 25 scholars most cited alongside İsmail Çimen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 164 | |
| 2 | 2016 | 87 | |
| 3 | 2019 | 71 | |
| 4 | 2013 | 43 | |
| 5 | 2009 | 41 | |
| 6 | 2011 | 35 | |
| 7 | 2011 | 34 | |
| 8 | 2012 | 34 | |
| 9 | 2020 | 27 | |
| 10 | 2022 | 26 | |
| 11 | 2019 | 22 | |
| 12 | 2023 | 21 | |
| 13 | 2020 | 21 | |
| 14 | 1986 | 11 | |
| 15 | 2017 | 10 |
About İsmail Çimen
İsmail Çimen is a scholar working on Pharmacology, Immunology, Oncology, Cell Biology and Biochemistry, having authored 15 papers that have together received 647 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (5 papers), Inflammatory mediators and NSAID effects (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Chemokine receptors and signaling (3 papers), Pancreatic function and diabetes (2 papers), NF-κB Signaling Pathways (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Cell Biology (140 citations), Biochemistry (45 citations), Immunology (124 citations), Cancer Research (80 citations) and Molecular Biology (275 citations). İsmail Çimen has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Sreeparna Banerjee, Ebru Erbay, Umut İnci Onat, Begüm Kocatürk, Özlem Tufanlı, Christian Weber, Syed Muhammad Hamid, Berna Savaş, Pelin Telkoparan‐Akillilar and Diego Acosta‐Alvear. Their work appears in journals such as Science Translational Medicine, Journal of Cellular Biochemistry, Molecular Metabolism, Basic Research in Cardiology and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.